{"component": "definition", "props": {"groups": [{"size": 108, "samples": [{"hash": "8ONzyEReNwL", "uri": "/contracts/8ONzyEReNwL#protocol", "label": "Not Specified", "score": 21.9271068573, "published": true}, {"hash": "4rE9fvtqGBT", "uri": "/contracts/4rE9fvtqGBT#protocol", "label": "Not Specified", "score": 21.8864555359, "published": true}, {"hash": "j5uC0Ju63pO", "uri": "https://prsindia.org/files/bills_acts/bills_parliament/2025/Protection_of_Interests_in_Aircraft_Objects_Bill_2025.pdf", "label": "prsindia.org", "score": 19.900598526, "published": false}], "snippet": "means, in respect of any category of object and associated rights to which this Convention applies, the Protocol in respect of that category of object and associated rights;", "snippet_links": [{"key": "in-respect-of", "type": "clause", "offset": [7, 20]}, {"key": "associated-rights", "type": "clause", "offset": [48, 65]}, {"key": "the-protocol", "type": "clause", "offset": [100, 112]}], "hash": "628704dbc6d6d320c2f41ff9e80e6f65", "id": 1}, {"size": 58, "samples": [{"hash": "5GkMBLkzgTp", "uri": "/contracts/5GkMBLkzgTp#protocol", "label": "Clinical Trial Research Agreement", "score": 36.0219306946, "published": true}, {"hash": "2TbGGWYRDUV", "uri": "/contracts/2TbGGWYRDUV#protocol", "label": "Clinical Trial Research Agreement", "score": 34.2770042419, "published": true}, {"hash": "4cqc0w8YGJU", "uri": "/contracts/4cqc0w8YGJU#protocol", "label": "Clinical Trial Research Agreement", "score": 34.0563812256, "published": true}], "snippet": "means the document identified in Schedule 6 which describes the objective(s), design, methodology, statistical considerations and organisation of the Study, and subject to clause 2.3, as amended from time to time, as agreed by the parties, and most recently approved by the Reviewing HREC.", "snippet_links": [{"key": "schedule-6", "type": "clause", "offset": [33, 43]}, {"key": "statistical-considerations", "type": "clause", "offset": [99, 125]}, {"key": "the-study", "type": "clause", "offset": [146, 155]}, {"key": "subject-to-clause", "type": "clause", "offset": [161, 178]}, {"key": "as-amended", "type": "definition", "offset": [184, 194]}, {"key": "from-time-to-time", "type": "clause", "offset": [195, 212]}, {"key": "by-the-parties", "type": "clause", "offset": [224, 238]}, {"key": "approved-by", "type": "clause", "offset": [258, 269]}, {"key": "reviewing-hrec", "type": "definition", "offset": [274, 288]}], "hash": "bdc03ebe63628a64b2fac49bc28dacff", "id": 2}, {"size": 50, "samples": [{"hash": "b8NheUjqWyi", "uri": "/contracts/b8NheUjqWyi#protocol", "label": "Madrid Agreement Concerning the International Registration of Marks", "score": 28.7960224152, "published": true}, {"hash": "iyeHvuQTJ9F", "uri": "/contracts/iyeHvuQTJ9F#protocol", "label": "Madrid Agreement Concerning the International Registration of Marks", "score": 28.3645343781, "published": true}, {"hash": "44GwSZFGEoF", "uri": "/contracts/44GwSZFGEoF#protocol", "label": "Madrid Agreement Concerning the International Registration of Marks", "score": 23.5462017059, "published": true}], "snippet": "means the Protocol Relating to the Madrid Agreement Concerning the International Registration of Marks, adopted at Madrid on June 27, 1989;", "snippet_links": [{"key": "the-protocol", "type": "clause", "offset": [6, 18]}, {"key": "relating-to", "type": "definition", "offset": [19, 30]}, {"key": "madrid-agreement", "type": "definition", "offset": [35, 51]}, {"key": "concerning-the", "type": "clause", "offset": [52, 66]}, {"key": "international-registration-of-marks", "type": "definition", "offset": [67, 102]}], "hash": "e4047772bb258ef8c3befbb41533abd1", "id": 3}, {"size": 48, "samples": [{"hash": "jTq1JP9hAnl", "uri": "/contracts/jTq1JP9hAnl#protocol", "label": "Term Loan Credit Agreement (Fly Leasing LTD)", "score": 31.8665294647, "published": true}, {"hash": "cbMpetCrgeV", "uri": "/contracts/cbMpetCrgeV#protocol", "label": "Aircraft Mortgage and Security Agreement (Fly Leasing LTD)", "score": 31.8665294647, "published": true}, {"hash": "cxtODwQvTsN", "uri": "/contracts/cxtODwQvTsN#protocol", "label": "Credit Agreement (Fortress Transportation & Infrastructure Investors LLC)", "score": 31.5790557861, "published": true}], "snippet": "means the Protocol to the Convention on Matters Specific to Aircraft Equipment, as in effect in any applicable jurisdiction from time to time.", "snippet_links": [{"key": "the-protocol", "type": "clause", "offset": [6, 18]}, {"key": "the-convention", "type": "clause", "offset": [22, 36]}, {"key": "aircraft-equipment", "type": "clause", "offset": [60, 78]}, {"key": "in-effect", "type": "definition", "offset": [83, 92]}, {"key": "applicable-jurisdiction", "type": "definition", "offset": [100, 123]}, {"key": "from-time-to-time", "type": "clause", "offset": [124, 141]}], "hash": "42207522c2de389b0e2f6da04a3fd396", "id": 4}, {"size": 45, "samples": [{"hash": "u7xFvECveA", "uri": "https://www.legis.iowa.gov/docs/aco/arc/3509C.pdf", "label": "Notice", "score": 12.9822044373, "published": false}, {"hash": "7vVsYqrDD7G", "uri": "https://pharmacy.iowa.gov/sites/default/files/notice_11-1-17_ch_8_re_5_yr_review_ch_39_expanded.pdf", "label": "Notice", "score": 12.9096508026, "published": false}, {"hash": "4y7MFDpjx0E", "uri": "https://www.legis.iowa.gov/docs/iac/chapter/06-16-2021.657.39.pdf", "label": "Note", "score": 12.4962358475, "published": false}], "snippet": "means a standing order for a vaccine to be administered by an authorized pharmacist.", "snippet_links": [{"key": "standing-order", "type": "definition", "offset": [8, 22]}, {"key": "authorized-pharmacist", "type": "definition", "offset": [62, 83]}], "hash": "d97e4b605de6cf70095223e6c4bf1e92", "id": 5}, {"size": 45, "samples": [{"hash": "5g8BhfRyNL", "uri": "https://biblioteca.corteidh.or.cr/engine/download/blob/cidh/168/2025/21/59438_1.pdf?app=cidh&class=2&id=42150&field=168", "label": "biblioteca.corteidh.or.cr", "score": 20.363609314, "published": false}, {"hash": "7JhxZ6mzgHB", "uri": "https://www.basel.int/Portals/4/download.aspx?e=UNEP-CHW-IMPL-CONVTEXT-2023.English.pdf", "label": "www.basel.int", "score": 19.5516777039, "published": false}, {"hash": "bAUyl51zM8u", "uri": "https://www.ukpandi.com/media/files/imports/13108/briefings/2808-prot-e.pdf", "label": "www.ukpandi.com", "score": 11.632443428, "published": false}], "snippet": "means the present Protocol;", "snippet_links": [], "hash": "1cc7c2cde54de6d00c265ace871060f4", "id": 6}, {"size": 43, "samples": [{"hash": "4oOMRBn9Z9q", "uri": "/contracts/4oOMRBn9Z9q#protocol", "label": "Cooperative Research and Development Agreement (Curative Biotechnology Inc)", "score": 33.3121147156, "published": true}, {"hash": "kdfUt8L3aWT", "uri": "/contracts/kdfUt8L3aWT#protocol", "label": "Cooperative Research and Development Agreement", "score": 31.6812076569, "published": true}, {"hash": "aslzHuR9mSZ", "uri": "/contracts/aslzHuR9mSZ#protocol", "label": "Cooperative Research and Development Agreement", "score": 31.3408622742, "published": true}], "snippet": "means the formal, detailed description of a study to be performed as provided for in the Research Plan. It describes the objective(s), design, methodology, statistical considerations, and organization of a trial. For the purposes of this CRADA, the term, Protocol, for clinical research involving Human Subjects, includes any and all associated documents, including informed consent forms, to be provided to Human Subjects and potential participants in the study.", "snippet_links": [{"key": "the-formal", "type": "clause", "offset": [6, 16]}, {"key": "description-of", "type": "clause", "offset": [27, 41]}, {"key": "research-plan", "type": "clause", "offset": [89, 102]}, {"key": "statistical-considerations", "type": "clause", "offset": [156, 182]}, {"key": "for-the-purposes-of", "type": "clause", "offset": [213, 232]}, {"key": "the-term", "type": "definition", "offset": [245, 253]}, {"key": "research-involving-human-subjects", "type": "clause", "offset": [278, 311]}, {"key": "associated-documents", "type": "definition", "offset": [334, 354]}, {"key": "informed-consent-forms", "type": "clause", "offset": [366, 388]}, {"key": "potential-participants", "type": "definition", "offset": [427, 449]}, {"key": "in-the-study", "type": "clause", "offset": [450, 462]}], "hash": "5344e5f8c8623687231d48ce682f0c69", "id": 7}, {"size": 42, "samples": [{"hash": "18SmyS8MMmw", "uri": "/contracts/18SmyS8MMmw#protocol", "label": "Stopia 2006 and Topia 2006", "score": 28.1253681183, "published": true}, {"hash": "bkOBptlgAtf", "uri": "/contracts/bkOBptlgAtf#protocol", "label": "Stopia 2006 and Topia 2006", "score": 28.1198940277, "published": true}, {"hash": "7GFlWbEwyPb", "uri": "/contracts/7GFlWbEwyPb#protocol", "label": "Small Tanker Oil Pollution Indemnification Agreement", "score": 28.1198940277, "published": true}], "snippet": "means the Protocol of 2003 to supplement the 1992 Fund Convention, and any domestic legislation giving effect thereto; and \u201cProtocol State\u201d means a State in respect of which the said Protocol is in force.", "snippet_links": [{"key": "the-protocol", "type": "clause", "offset": [6, 18]}, {"key": "fund-convention", "type": "definition", "offset": [50, 65]}, {"key": "domestic-legislation", "type": "clause", "offset": [75, 95]}, {"key": "protocol-state", "type": "definition", "offset": [124, 138]}, {"key": "in-respect-of", "type": "clause", "offset": [154, 167]}, {"key": "in-force", "type": "definition", "offset": [195, 203]}], "hash": "af1d27d43bfe4915ea04118254219ef3", "id": 8}, {"size": 39, "samples": [{"hash": "9bEQ8nlznjR", "uri": "/contracts/9bEQ8nlznjR#protocol", "label": "Clinical Trial Research Agreement", "score": 31.6374111176, "published": true}, {"hash": "3xSpHYHWTVC", "uri": "/contracts/3xSpHYHWTVC#protocol", "label": "Clinical Trial Research Agreement", "score": 30.9138851166, "published": true}, {"hash": "7SJQYchHWKf", "uri": "/contracts/7SJQYchHWKf#protocol", "label": "Clinical Trial Research Agreement", "score": 30.6291980743, "published": true}], "snippet": "means the document identified in Schedule 3 which describes the objective(s), design, methodology, statistical considerations and organisation of the Study, and subject to clause 2.3, as amended from time to time, as agreed by the parties, and most recently approved by the Reviewing HREC.", "snippet_links": [{"key": "schedule-3", "type": "clause", "offset": [33, 43]}, {"key": "statistical-considerations", "type": "clause", "offset": [99, 125]}, {"key": "the-study", "type": "clause", "offset": [146, 155]}, {"key": "subject-to-clause", "type": "clause", "offset": [161, 178]}, {"key": "as-amended", "type": "definition", "offset": [184, 194]}, {"key": "from-time-to-time", "type": "clause", "offset": [195, 212]}, {"key": "by-the-parties", "type": "clause", "offset": [224, 238]}, {"key": "approved-by", "type": "clause", "offset": [258, 269]}, {"key": "reviewing-hrec", "type": "definition", "offset": [274, 288]}], "hash": "77652994b52efed4654a2fe6cfc3bf5d", "id": 9}, {"size": 36, "samples": [{"hash": "7VJsF5PxJwC", "uri": "/contracts/7VJsF5PxJwC#protocol", "label": "Clinical Trial Collaboration and Supply Agreement (Context Therapeutics Inc.)", "score": 33.6078033447, "published": true}, {"hash": "ajBG5FDJd8z", "uri": "/contracts/ajBG5FDJd8z#protocol", "label": "Clinical Trial Collaboration and Supply Agreement (IDEAYA Biosciences, Inc.)", "score": 33.3531837463, "published": true}, {"hash": "7anYgKWZaz8", "uri": "/contracts/7anYgKWZaz8#protocol", "label": "Clinical Trial Collaboration and Supply Agreement (IDEAYA Biosciences, Inc.)", "score": 33.3531837463, "published": true}], "snippet": "means the written documentation that describes the Study and sets forth specific activities to be performed as part of the Study conduct, a summary of which is attached hereto as Appendix A.", "snippet_links": [{"key": "written-documentation", "type": "definition", "offset": [10, 31]}, {"key": "the-study", "type": "clause", "offset": [47, 56]}, {"key": "activities-to-be-performed", "type": "clause", "offset": [81, 107]}, {"key": "study-conduct", "type": "clause", "offset": [123, 136]}], "hash": "cce836f621c67d38fa795ad58253a0f3", "id": 10}], "next_curs": "ClUST2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjELEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIRcHJvdG9jb2wjMDAwMDAwMGEMogECZW4YACAA", "definition": {"size": 3195, "snippet": "means, in respect of any category of object and associated rights to which this Convention applies, the Protocol in respect of that category of object and associated rights;", "title": "Protocol", "id": "protocol", "examples": ["In the event of any inconsistencies between this Confirmation and the terms of the <strong>Protocol</strong>, the Bilateral Agreement or the Bilateral Terms (each, the \u201cQFC Stay Terms\u201d), as applicable, the QFC Stay Terms will govern.", "The parties further agree that, solely for purposes of applying such provisions and amendments to the Agreement with respect to the Transaction, references to \u201ceach Covered Master Agreement\u201d in the 871(m) <strong>Protocol</strong> will be deemed to be references to the Agreement with respect to the Transaction, and references to the \u201cImplementation Date\u201d in the 871(m) <strong>Protocol</strong> will be deemed to be references to the Trade Date of the Transaction.", "The parties agree that the definitions contained in Section 4 of, and the provisions in the Attachment to, the ISDA 2013 EMIR Portfolio Reconciliation, Dispute Resolution and Disclosure <strong>Protocol</strong> published on 19th of July 2013 by the International Swaps and Derivatives Association, Inc.", "For these purposes, the term \u201cCovered SBS Entity,\u201d as used in the SBS Top-Up <strong>Protocol</strong>, is hereby agreed to refer to Party A and the terms \u201cCounterparty\u201d and \u201cCP,\u201d as used in the SBS Top-Up <strong>Protocol</strong>, are hereby agreed to refer to Party B.", "The Parties agree that the definitions and provisions contained in the SBS Top-Up <strong>Protocol</strong>, including Appendix 1 and/or Appendix 2 thereto, as applicable, or for parties that instead executed an alternative bilateral top-up, such bilateral top-up, are hereby incorporated into and apply to this Agreement as if set forth in full herein.", "In this respect, references in those definitions and provisions to any \u201cISDA Master Agreement\u201d will be deemed to be references to this Agreement and the term &quot;the parties&quot;, as used in the EMIR <strong>Protocol</strong>, shall be construed as referring to Party A and Party B.", "The parties agree that this Agreement shall be considered a \u201c<strong>Protocol</strong> Covered Agreement\u201d or a \u201cCovered Agreement,\u201d as applicable, for purposes of the ISDA August 2012 DF <strong>Protocol</strong> and the ISDA March 2013 DF <strong>Protocol</strong>.", "The parties agree that the definitions and provisions contained in Annexes 1 to 16 and Section 6 of the 2002 Master Agreement <strong>Protocol</strong> published by the International Swaps and Derivatives Association, Inc.", "The SBS Top-Up <strong>Protocol</strong> is available at https://\u2587\u2587\u2587.\u2587\u2587\u2587\u2587.\u2587\u2587\u2587/\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587/isda-2021-sbs-top-up-<strong>protocol</strong>/.", "To the extent the parties have agreed to engage in portfolio reconciliation pursuant to Commodity Futures Trading Commission (\u201cCFTC\u201d) Rule 23.502 (17 C.F.R. 23.502) and Securities and Exchange Commission (\u201cSEC\u201d) Rule 15Fi-3 (17 C.F.R. 240.15Fi-3) by incorporating Schedule 4 of the Supplement to the ISDA March 2013 DF <strong>Protocol</strong> Agreement (as published by the International Swaps and Derivatives Association, Inc."], "related": [["kyoto-protocol", "Kyoto Protocol", "Kyoto <strong>Protocol</strong>"], ["protocols", "Protocols", "<strong>Protocols</strong>"], ["aircraft-protocol", "Aircraft Protocol", "Aircraft <strong>Protocol</strong>"], ["step-therapy-protocol", "Step therapy protocol", "Step therapy <strong>protocol</strong>"], ["study", "Study", "Study"]], "related_snippets": [], "updated": "2026-06-09T05:48:27+00:00"}, "json": true, "cursor": ""}}